The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Decreased Fat Mass in Interleukin-1 Receptor Antagonist–Deficient Mice
Open accessAbstract
Interleukin (IL)-1 is a regulator of inflammation but is also implicated in the control of energy homeostasis. Because the soluble IL-1 receptor antagonist (IL-1Ra) is markedly increased in the serum of obese patients and is overexpressed in white adipose tissue in obesity, we studied the metabolic consequences of genetic IL-1Ra ablation in mice. We have shown that IL-1Ra−/− mice have a lean phenotype due to decreased fat mass, related to a defect in adipogenesis and increased energy expenditure. The adipocytes were smaller in these animals, and the expression of genes involved in adipogenesis was reduced. Energy expenditure as measured by indirect calorimetry was elevated, and weight loss in response to a 24-h fast was increased in IL-1Ra−/− animals compared with wild-type mice. Lipid oxidation of IL-1Ra−/− mice was higher during the light period, reflecting their reduction in diurnal food intake. Interestingly, IL-1Ra−/− and IL-1Ra+/− mice presented an attenuation in high-fat diet–induced caloric hyperphagia, indicating a better adaptation to hypercaloric alimentation, which is in line with the role of IL-1Ra as a mediator of leptin resistance. Taken together, we show that IL-1Ra is an important regulator of adipogenesis, food intake, and energy expenditure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increase in abdominal fat mass is associated with a chronic elevation of the circulating concentrations of inflammatory mediators including several acute-phase inflammatory proteins such as CRP (46,47) , proand anti-inflammatory cytokines, adhesion molecules and pro-thrombotic molecules (22,47 -49) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cytokines suppress adipogenesis and PPAR-γ function through the TAK1/TAB1/NIK cascade
Suzawa, M., Takada, I., Yanagisawa, J., Ohtake, F., Ogawa, S., Yamauchi, T., Kadowaki, T., Takeuchi, Y., Shibuyà, H., Gotoh, Y., et al. (2003) · Nature Cell Biology · doi:10.1038/ncb942 · Cited by 292
RetractedAdipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Kleiber, M. (1947) · Physiological Reviews · doi:10.1152/physrev.1947.27.4.511 · Cited by 1,817
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504
Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., & Thompson, R. C. (1990) · Nature · doi:10.1038/343336a0 · Cited by 1,122
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,113
Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E. L., Brewer, M. T., Hannum, C. H., & Thompson, R. C. (1990) · Nature · doi:10.1038/343341a0 · Cited by 1,084
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,006
Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist
Dinarello, C. A. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043005 · Cited by 761
Cited by
Sorted by citations
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
Proinflammatory Cytokines, Aging, and Age-Related Diseases
Michaud, M., Balardy, L., Moulis, G., Gaudin, C., Peyrot, C., Vellas, B., Cesari, M., & Nourhashemi, F. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.009 · Cited by 1,094
Adipose Tissue-Derived Factors: Impact on Health and Disease
Trujillo, M. E., & Scherer, P. E. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0033 · Cited by 624
“Certainly additional adipokines may soon be added to this list including IL-1 (164, 165), IL-8 (166, 167), IL-18 (168), and IL-10 (169).”
BackgroundLeptin resistance and diet-induced obesity: central and peripheral actions of leptin
Sáinź, N., Barrenetxe, J., Moreno-Aliaga, M. J., & Martínez, J. A. (2014) · Metabolism · doi:10.1016/j.metabol.2014.10.015 · Cited by 445
Poggi, M., Bastelica, D., Gual, P., Iglesias, M. A., Grémeaux, T., Knauf, C., Peiretti, F., Verdier, M., Juhan-Vague, I., Tanti, J., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0654-8 · Cited by 361
“3a), recently shown to regulate adipogenesis, food intake and energy expenditure [32].”
The role of interleukins in insulin resistance and type 2 diabetes mellitus
Fève, B., & Bastard, J.-P. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.62 · Cited by 343
IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat
Ehses, J. A., Lacraz, G., Giroix, M.-H., Schmidlin, F., Coulaud, J., Kassis, N., Irminger, J.-C., Kergoat, M., Portha, B., Homo-Delarche, F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810087106 · Cited by 354
“paradoxically develop maturity-onset obesity (28), while IL-1Ra KO mice are lean and resist HFD induced obesity ( 29 , 30).”
BackgroundBeyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 357
Chronic adipose tissue inflammation: all immune cells on the stage
Cildir, G., Akıncılar, S. C., & Tergaonkar, V. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.05.001 · Cited by 329
NLRP3 at the interface of metabolism and inflammation
Haneklaus, M., & O'Neill, L. A. J. (2015) · Immunological Reviews · doi:10.1111/imr.12285 · Cited by 296
Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance
Al-Mansoori, L., Al-Jaber, H., Prince, M. S., & Elrayess, M. A. (2021) · Inflammation · doi:10.1007/s10753-021-01559-z · Cited by 319
Insulin signalling mechanisms for triacylglycerol storage
Czech, M., Tencerová, M., Pedersen, D. J., & Aouadi, M. (2013) · Diabetologia · doi:10.1007/s00125-013-2869-1 · Cited by 289
Shelton, R. C., & Miller, A. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.004 · Cited by 264
Ballak, D. B., Stienstra, R., Tack, C. J., Dinarello, C. A., & van Diepen, J. A. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.005 · Cited by 265
“Furthermore IL-1Ra knockout mice, characterized by enhanced IL-1 signaling, are resistant to obesity [76].”
BackgroundRen, Y., Zhao, H., Yin, C., Lan, X., Wu, L., Du, X., Griffiths, H. R., & Gao, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873699 · Cited by 276
The development and endocrine functions of adipose tissue
Poulos, S. P., Hausman, D. B., & Hausman, G. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.12.011 · Cited by 236
Cytokines and β-Cell Biology: from Concept to Clinical Translation
Donath, M. Y., Størling, J., Berchtold, L. A., Billestrup, N., & Mandrup-Poulsen, T. R. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0033 · Cited by 222
Hypothalamic Inflammation: Marker or Mechanism of Obesity Pathogenesis?
Thaler, J. P., Guyenet, S. J., Dorfman, M. D., Wisse, B. E., & Schwartz, M. W. (2013) · Diabetes · doi:10.2337/db12-1605 · Cited by 215
“Conversely, IL-1 receptor antagonist– deficient mice show a lean, hypermetabolic phenotype with increased leptin sensitivity despite higher levels of IL-1 activity (47).”
BackgroundMcGillicuddy, F. C., Harford, K. A., Reynolds, C. M., Oliver, E., Claessens, M., Mills, K. H. G., & Roche, H. M. (2011) · Diabetes · doi:10.2337/db10-1278 · Cited by 199
“On the contrary, IL-1Ra mice exhibit a lean phenotype with increased energy expenditure and hypoinsulinemia (39,40).”
BackgroundThe Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
Packer, M. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.06.055 · Cited by 213
Inflammation during obesity is not all bad: evidence from animal and human studies
Ye, J., & McGuinness, O. P. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2012 · Cited by 178
The Inflammasome in Atherosclerosis and Type 2 Diabetes
Masters, S. L., Latz, E., & O’Neill, L. A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001902 · Cited by 169
IL‐1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?
Perrier, S., Darakhshan, F., & Hajduch, É. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.061 · Cited by 173
“cient to block IL-1 activity at a systemic and/or local levels [53].”
BackgroundMethodInfluentialCook, D. N., Kang, H. S., & Jetten, A. M. (2015) · Nuclear Receptor Research · doi:10.11131/2015/101185 · Cited by 181
Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency
Zorrilla, E. P., Sánchez-Alavez, M., Sugama, S., Brennan, M., Fernandez, R. E., Bartfai, T., & Conti, B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611523104 · Cited by 170
Ye, J., & Keller, J. N. (2010) · Aging · doi:10.18632/aging.100155 · Cited by 175
Local adipose tissue depots as cardiovascular risk factors
Thalmann, S., & MEIER, C. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.008 · Cited by 166
Self-citationHypothalamic inflammation: a double‐edged sword to nutritional diseases
Cai, D., & Liu, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06388.x · Cited by 162
Hypothalamic mechanisms in cachexia
Grossberg, A. J., Scarlett, J. M., & Marks, D. L. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.03.011 · Cited by 162
“In the absence of infection or tissue damage, cytokine expression in the brain remains very low, though basal cytokine levels may play a role in sleep and energy balance [43-46].”
Tang, T., Zhang, J., Yin, J., Staszkiewicz, J., Gawrońska‐Kozak, B., Jung, D. Y., Ko, H. J., Ong, H., Kim, J. K., Mynatt, R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068007 · Cited by 164
Kamari, Y., Werman-Venkert, R., Shaish, A., Werman, A., Harari, A., Gonen, A., Voronov, E., Grosskopf, I., Sharabi, Y., Grossman, E., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.026 · Cited by 106
Kang, H. S., Okamoto, K., Kim, Y.-S., Takeda, Y., Bortner, C. D., Dang, H., Wada, T., Xie, W., Yang, X.-P., Liao, G., et al. (2010) · Diabetes · doi:10.2337/db10-0628 · Cited by 105
“In this regard, the repression of Il1rn expression in TAK1 / WAT is particularly interesting because upregulation of this gene has been reported to be associated with obesity whereas Il1rn KO mice have been shown to be resistant to obesity (45,46).”
BackgroundAdipose tissue inflammation in glucose metabolism
Kammoun, H. L., Kraakman, M. J., & Febbraio, M. A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9274-4 · Cited by 101
Cytokines and inflammation in adipogenesis: an updated review
Jiang, N., Yao, L., Shu, T., & Wang, J. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0625-0 · Cited by 104
Why is obesity associated with osteoarthritis? Insights from mouse models of obesity
Griffin, T. M., & Guilak, F. (2008) · Biorheology · doi:10.3233/bir-2008-0485 · Cited by 99
Pinteaux, E., Inoue, W., Schmidt, L., Molina‐Holgado, F., Rothwell, N. J., & Luheshi, G. N. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04559.x · Cited by 99
“This observation is in agreement with published studies showing that IL-1RA is readily detectable in both the circulation and brain of normal human and rodents (Palin et al. 2004; Somm et al. 2005), as well as culture medium of untreated primary human liver cells (Gabay et al. 1997).”
BackgroundResultInfluentialGhanbari, M., Maragheh, S. M., Aghazadeh, A., Mehrjuyan, S. R., Hussen, B. M., Shadbad, M. A., Dastmalchi, N., & Safaralizadeh, R. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107765 · Cited by 101
Rafiq, S., Stevens, K., Hurst, A. J., Murray, A., Henley, W., Weedon, M. N., Bandinelli, S., Corsi, A. M., Guralnik, J. M., Ferruci, L., et al. (2007) · Genes & Immunity · doi:10.1038/sj.gene.6364393 · Cited by 92
KLB, encoding β‐Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism
Xu, C., Messina, A., Somm, E., Miraoui, H., Kinnunen, T. K., Acierno, J. S., Niederländer, N. J., Bouilly, J., Dwyer, A. A., Sidis, Y., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607376 · Cited by 98
“The average V O 2 was calculated during 48 h — two light cycles and two dark cycles (Somm et al , 2005, 2014).”
MethodSelf-citationKang, H. S., Okamoto, K., Takeda, Y., Beak, J. Y., Gerrish, K., Bortner, C. D., DeGraff, L. M., Wada, T., Xie, W., & Jetten, A. M. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00206.2010 · Cited by 95
Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesity
Li, Y., Mouche, S., Sajic, T., Veyrat‐Durebex, C., Supale, R., Pierroz, D. D., Ferrari, S., Negro, F., Hasler, U., Féraille, E., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.279 · Cited by 84
Role of IL‐38 and Its Related Cytokines in Inflammation
Yuan, X., Peng, X., Li, Y., & Li, M. (2015) · Mediators of Inflammation · doi:10.1155/2015/807976 · Cited by 83
“damage [40], lung damage [41], fat mass [42], and aqueous-”
BackgroundRole of caspase-1 in regulation of triglyceride metabolism
Kotas, M. E., Jurczak, M. J., Annicelli, C., Gillum, M. P., Cline, G. W., Shulman, G. I., & Medzhitov, R. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301996110 · Cited by 76
Stress-induced cytokine responses and central adiposity in young women
Brydon, L., Wright, C. E., O'Donnell, K., Zachary, I., Wardle, J., & Steptoe, A. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803767 · Cited by 72
Gomez-Mérino, D., Drogou, C., Guezennec, C. Y., & Chennaoui, M. (2007) · Cytokine · doi:10.1016/j.cyto.2007.07.188 · Cited by 69
Emerging role of interleukin-1 in cardiovascular diseases
Vicenová, B., Vopálenský, V., Burýšek, L., & Pospíšek, M. (2009) · Physiological Research · doi:10.33549/physiolres.931673 · Cited by 64
Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications
Fonseka, T. M., Müller, D. J., & Kennedy, S. H. (2016) · Complex Psychiatry · doi:10.1159/000441521 · Cited by 68
Becattini, B., Marone, R., Zani, F., Arsenijevic, D., Seydoux, J., Montani, J., Dulloo, A. G., Thorens, B., Preitner, F., Wymann, M. P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106698108 · Cited by 59
IL-1 induces mitochondrial translocation of IRAK2 to suppress oxidative metabolism in adipocytes
Zhou, H., Wang, H., Yu, M., Schugar, R. C., Qian, W., Tang, F., Liu, W., Yang, H., McDowell, R. E., Zhao, J., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0750-1 · Cited by 58
Caspases and inflammasomes in metabolic inflammation
Skeldon, A. M., Faraj, M., & Saleh, M. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.5 · Cited by 55
Osborn, O., Gram, H., Zorrilla, E., Conti, B., & Bartfai, T. (2008) · Swiss Medical Weekly · doi:10.4414/smw.2008.12276 · Cited by 53
Ballak, D. B., Li, S., Cavalli, G., Stahl, J. L., Tengesdal, I. W., van Diepen, J. A., Klück, V., Swartzwelter, B. J., Azam, T., Tack, C. J., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003698 · Cited by 55
Molero, J. C., Turner, N. A., Thien, C. B. F., Langdon, W. Y., James, D. E., & Cooney, G. J. (2006) · Diabetes · doi:10.2337/db06-0955 · Cited by 47
“The second group of mice are those in which there has been a disruption of genes involved in lipid storage, such as ACC2 (25), acyl-CoA diacylglycerol acyl-transferase (DGAT) (26), acylation-stimulating protein (ASP) (27), stearoylCoA desaturase-1 (SCD-1) (28), and interleukin-1 receptor antagonist (IL-1Ra) (29).”
Backgroundvan Diepen, J. A., Stienstra, R., Vroegrijk, I. O. C. M., van den Berg, S. A. A., Salvatori, D. C. F., Hooiveld, G. J. E. J., Kersten, S., Tack, C. J., Netea, M. G., Smit, J. W. A., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m031963 · Cited by 46
Gut hormone GIP induces inflammation and insulin resistance in the hypothalamus
Fu, Y., Kaneko, K., Lin, H.-Y., Mo, Q., Xu, Y., Suganami, T., Ravn, P., & Fukuda, M. (2020) · Endocrinology · doi:10.1210/endocr/bqaa102 · Cited by 38
Somm, E., Vauthay, D. M., Guérardel, A., Toulotte, A., Cettour-Rose, P., Klee, P., Meda, P., Aubert, M. L., Hüppi, P. S., & Schwitzgebel, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050131 · Cited by 37
“This observation was also confirmed by the down-expression in eWAT from UN pups of IL-1 receptor antagonist (Il1rn), an acute-phase adipokine intervening in the counterregulation of the inflammatory processes [51] and characterized as a good marker of adiposity [52], [53].”
BackgroundSelf-citationMcGillicuddy, F. C., Reynolds, C. M., Finucane, O., Coleman, E., Harford, K. A., Grant, C., Sergi, D., Williams, L. M., Mills, K. H. G., & Roche, H. M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2013 · Cited by 36
Fang, M., Fan, Z., Tian, W., Zhao, Y., Li, P., Xu, H., Zhou, B., Zhang, L., Wu, X., & Xu, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.11.010 · Cited by 35
Metabolic Characterization of a Mouse Deficient in All Known Leptin Receptor Isoforms
Osborn, O., Sánchez-Alavez, M., Brownell, S. E., Ross, B. S., Klaus, J., Dubins, J. S., Beutler, B., Conti, B., & Bartfai, T. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9427-x · Cited by 35
Frühbeck, G., Catalán, V., Ramírez, B., Valentí, V., Becerril, S., Rodríguez, A., Moncada, R., Baixauli, J., Silva, C., Escalada, J., et al. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s354095 · Cited by 37
Say, Y.-H. (2017) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/s40101-017-0142-x · Cited by 29
Increased plasma interleukin-1 receptor antagonist levels in men with visceral obesity
Cartier, A., Bergeron, J., Poirier, P., Alméras, N., Tremblay, A., Lemieux, I., & Després, J. (2009) · Annals of Medicine · doi:10.1080/07853890903022801 · Cited by 28
“In vivo studies also showed that IL-1Ra-deficient mice exhibit an elevated metabolic rate and a reduced caloric intake following a high-fat diet (24).”
BackgroundFrühbeck, G., Catalán, V., Ramírez, B., Valentí, V., Becerril, S., Rodríguez, A., Moncada, R., Baixauli, J., Silva, C., Escalada, J., et al. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 27
Molecular pathways linking metabolic inflammation and thermogenesis
Solinas, G. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01047.x · Cited by 28
“Indeed it has been shown that mice that do not express IL-1Ra, a most potent antagonist of IL-1 signalling, display decreased weight gain and increased energy expenditure (73).”
BackgroundHsp72, inflammation, and aging: causes, consequences, and perspectives
Ortega, E., Bote, E., Besedovsky, H. O., & del Rey, A. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06619.x · Cited by 26
IL-1R Regulates Disease Tolerance and Cachexia in Toxoplasma gondii Infection
Melchor, S. J., Saunders, C. M., Sanders, I., Hatter, J. A., Byrnes, K. A., Coutermarsh‐Ott, S. L., & Ewald, S. E. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000159 · Cited by 26
Whitaker, K. W., & Reyes, T. M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.014 · Cited by 25
Knock-Down of IL-1Ra in Obese Mice Decreases Liver Inflammation and Improves Insulin Sensitivity
Franck, N., Maris, M., Nalbandian, S., Talukdar, S., Schenk, S., Hofmann, H.-P., Bullough, D. A., & Osborn, O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107487 · Cited by 24
“IL-1Ra knockdown in HFD-fed mice resembles the phenotype previously observed in IL-1Ra KO mice, whom display increased energy expenditure, increased oxygen consumption and higher CBT [22,23,42].”
BackgroundInfluentialLeptin Resistance and the Neuro-Adipose Connection
Barateiro, A. P., Mahú, I., & Domingos, A. I. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00045 · Cited by 23
Innate-Immunity Genes in Obesity
Михайлова, С. В., & Иванощук, Д. Е. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111201 · Cited by 25
Chida, D., Hashimoto, O., Kuwahara, M., Sagara, H., Osaka, T., Tsubone, H., & Iwakura, Y. (2008) · Diabetologia · doi:10.1007/s00125-008-1075-z · Cited by 20
“diet [ 10 ], we only detected a significant increase in energy expenditure on a HFD; the discrepancy is probably due to differences in the diet or housing conditions.”
BackgroundResultInfluentialCharacteristic and fate determination of adipose precursors during adipose tissue remodeling
Ye, J., Gao, C. D., Liang, Y., Hou, Z., Shi, Y., & Wang, Y. (2023) · Cell Regeneration · doi:10.1186/s13619-023-00157-8 · Cited by 19
Morine, M. J., Toomey, S., McGillicuddy, F. C., Reynolds, C. M., Power, K. A., Browne, J. A., Loscher, C. E., Mills, K. H. G., & Roche, H. M. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.04.012 · Cited by 18
Association between IL-1β + 3954C/T polymorphism and myocardial infarction risk
Fang, Y., Xie, H., & Lin, Z. (2018) · Medicine · doi:10.1097/md.0000000000011645 · Cited by 17
Goto, H., Ishihara, Y., Kikuchi, T., Izawa, A., Ozeki, N., Okabe, E., Kamiya, Y., Ozawa, Y., Mizutani, H., Yamamoto, G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140942 · Cited by 14
Variants of the interleukin-1 receptor antagonist gene are associated with fat mass in men
Andersson, N., Strandberg, L., Nilsson, S., Ljunggren, Ö., Karlsson, M. K., Mellström, D., Lorentzon, M., Ohlsson, C., & Jansson, J.-O. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.47 · Cited by 14
Kok, Y.-Y., Ong, H.-H., & Say, Y.-H. (2017) · Journal of Obesity · doi:10.1155/2017/4104137 · Cited by 13
“IL-1ra is a proadipogenic factor as IL1RA knockoutmice have reduced adipose storage, impaired adipogenesis, and decrease in adipocyte size [6], while its level is increased in the serum of obese patients, correlating with body mass index (BMI) and insulin resistance [7].”
BackgroundAdipose targets for obesity drug development
Boss, O., & Bergenhem, N. C. H. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.119 · Cited by 12
“This supports the concept that the lean phenotype induced by IL-1Ra deficiency is due to a constitutively increased IL-1 signalling [129].”
BackgroundAssociation between Interleukin-1B C-31T Polymorphism and Obesity in Japanese
Suzuki, K. A. O., Inoue, T., Yanagisawa, A., Kimura, A., Ito, Y., & Hamajima, N. (2009) · Journal of Epidemiology · doi:10.2188/jea.je20081015 · Cited by 12
Yang, S.-A. (2014) · Journal of Exercise Rehabilitation · doi:10.12965/jer.140155 · Cited by 11
Sherry, C. L., Kim, S. S., & Freund, G. G. (2009) · Endocrinology · doi:10.1210/en.2008-1622 · Cited by 11
Pinteaux, E., Abdulaal, W. H., Mufazalov, I. A., Humphreys, N. E., Jackson, M. S., Francis, S., Müller, W., & Waisman, A. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01928-5 · Cited by 11
“Indeed, normal bone growth and remodeling are altered in IL-1R1 and IL-1α/ βmice [36, 37], whereas decrease body fat mass is reduced in IL-1Ra mice [38], strongly suggesting that significant phenotypic changes occur after ubiquitous deletion of IL-1 family members.”
BackgroundCytokines and regulation of glucose and lipid metabolism in the obesity
Scherbakov, V. I., Александровна, С. Г., Ryabichenko, T. I., & Обухова, О. О. (2022) · Obesity and metabolism · doi:10.14341/omet12863 · Cited by 10
IL-1β directly suppress ghrelin mRNA expression in ghrelin-producing cells
Bando, M., Iwakura, H., Ueda, Y., Ariyasu, H., Inaba, H., Furukawa, Y., Furuta, H., Nishi, M., & Akamizu, T. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.032 · Cited by 10
Interleukins in adipose tissue: Keeping the balance
Antuna-Puente, B., Fellahi, S., McAvoy, C., Fève, B., & Bastard, J. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111531 · Cited by 11
Nuclear Receptor RORα/γ: Exciting Modulators in Metabolic Syndrome and Related Disorders
Gu, H., Hu, P., Zhao, Y., Liu, Y., Wang, Y.-T., Ahmed, A. A., Liu, H., & Cai, D. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.925267 · Cited by 9
“Because of the potential role of interleukin-1 receptor antagonist (IL1rn) in IR, the reduced Il-1rn expression in adipose tissue of RORα mice possibly leads to less susceptibility to MetS (36).”
BackgroundElhage, R., Ljunggren, H., & Hansson, G. K. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs220 · Cited by 8
Obesity and type 2 diabetes as chronic inflammation: how does the cytokine evidence align?
Bhatia, K., Gupta, V. K., & Upadhyay, S. K. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1721206 · Cited by 15
Tissu adipeux, inflammation et athérome
Meier, C. A., & Thalmann, S. (2007) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)33028-6 · Cited by 7
Self-citationInterleukin-1 receptor antagonist gene polymorphism and obesity: A pilot study from north India
Manchanda, P., Bid, H. K., Achyut, B. R., Mittal, B., Srivastava, N., & Mittal, R. D. (2007) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02912883 · Cited by 6
“It is an important regulator of adipogenesis, food intake, and energy expenditure (9)”
BackgroundGuest, C. B., Gao, Y., O’Connor, J. C., & Freund, G. G. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50054-x · Cited by 6
Mediation of glucose-induced anorexia by central nervous system interleukin 1 signaling
Mizuno, T. M., Lew, P. S., Spirkina, A., & Xu, Y. X. Z. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.050 · Cited by 6
Adipose Tissue Development in Extramuscular and Intramuscular Depots in Meat Animals
Hausman, G. J., & Poulos, S. P. (2009) · CRC Press eBooks · doi:10.1201/b15797-4 · Cited by 5
Tada, A., Kober, A. K. M. H., Islam, M. A., Igata, M., Takagi, M., Suzuki, M., Aso, H., Ikeda‐Ohtsubo, W., Yoda, K., Miyazawa, K., et al. (2020) · Cells · doi:10.3390/cells9071715 · Cited by 6
“Furthermore, IFN-β protected animals against adipose tissue inflammation [64].”
BackgroundNatural Compounds Exert Anti‐Obesity Effects by Regulating Cytokines
Zhang, Y., Feng, G., Zhang, W., & Liu, X. (2025) · Phytotherapy Research · doi:10.1002/ptr.8508 · Cited by 5
Ueland, T., Jørgensen, A. P., Godang, K., Fougner, K. J., Aukrust, P., Burman, P., & Bollerslev, J. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03884.x · Cited by 2
Lachmann, H. J., Arnold, R. J. G., Gattorno, M., Koné‐Paut, I., Ferreira, A., & Kümmerle-Deschner, J. B. (2013) · Journal of health economics and outcomes research · doi:10.36469/9860 · Cited by 2
Interactions between nutrition, obesity and the immune system
Strandberg, L. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 2
Leptin resistance and left ventricular hypertrophy in obese children and adolescents
Ormond, D. K. (2012) · doi:10.6083/m4q23x7g · Cited by 1
Adipokines, Inflammation, and Obesity
Clément, K. (2010) · Wiley eBooks · doi:10.1002/9783527629527.ch14 · Cited by 1
Metadata
- Authors
- Somm, E., Henrichot, E., Pernin, A., Juge-Aubry, C. E., Muzzin, P., Dayer, J.-M., Nicklin, M. J. H., & Meier, C. A.
- Affiliations
- University Hospital of Geneva (CH)
- Endocrine Unit, Department of Internal Medicine, University Hospital, and Department of Cellular Physiology and Metabolism, University Medical Center, Geneva, Switzerland
- University of Geneva (CH)
- Royal Hallamshire Hospital (GB)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2005-12-01
- Volume
- 54
- Issue
- 12
- Pages
- 3503-3509
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2144150240
- Cited by
- 114
- References
- 42
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 1 · 2015: 6 · 2014: 5 · 2013: 9 · 2012: 9
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- interleukin-1 receptor antagonist, fat mass, adipogenesis, energy expenditure, obesity, leptin resistance, dietary intake, high-fat diet, lipid oxidation, diurnal feeding, adipocyte size, energy homeostasis
- MeSH terms
- Adipose Tissue, Animals, Body Composition, Energy Intake, Energy Metabolism, Gene Amplification, Interleukin-1, Introns, Male, Obesity, Sialoglycoproteins, Weight Gain, Weight Loss, Interleukin-6, Mice, Knockout, Mice, Interleukin 1 Receptor Antagonist Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
